2021-01-04,"b""Monday's Top Flow in #healthcare sector, Buy Flow &amp; Sell Flow $UNH $ABC $GILD $DVA $MCK $PRGO $BDX $PFE $WAT $AMGN $JNJ $BSX $BMY $TMO $VRTX $MDT $CI $ISRG $REGN $SYK #stock #stocks #StockMarket #Investment #investing #HealthTech https://t.co/5JE2nlrW3B https://t.co/eLkemtdzJu"""
2021-01-04,b'@aserritella1984 @hankmardukas99 You and me both. The most disappointing part is that it was super close. I truly believe $BMY management believed it will get approved when they responded on Dec 18. No idea what the last hiccup was.'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,"b""@given2tweet I realize that $8B is about 5% of $BMY 's equity market cap, but given my belief that all three end points will be successfully hit by March, they did just get handed a decent sized check. Mr Market didn't care."""
2021-01-04,"b""#3\nA $6B CVR goes pfffft as the game clock runs out on a New Year's deadline for Bristol Myers' liso-cel application\n$BMY\nhttps://t.co/VRuK0t0d6c"""
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @WallStJesus: $BMY  LATE AFTERNOON BULL FLOW ..'
2021-01-04,b'RT @WallStJesus: $BMY  LATE AFTERNOON BULL FLOW ..'
2021-01-04,b'$BMY  LATE AFTERNOON BULL FLOW ..'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'$BMY Feb 19 $62.5 calls are a gift today. Buy some and be rewarded. $1.80 is cheap when these will be worth $6+.'
2021-01-04,b'How an all-or-nothing bet on 3 Bristol Myers drugs came undone https://t.co/RvJp1VNZnm by @NedPagliarulo $BMY'
2021-01-04,b'RT @BentheFidler: How an all-or-nothing bet on 3 Bristol Myers drugs came undone https://t.co/vnh3M6VaOR by @NedPagliarulo $BMYRT $BMY $CELG'
2021-01-04,b'$BMY Valuation Ratios vs Time_Trailing metrics https://t.co/pgvmyJDCXR #ValuationRatios #BMY https://t.co/j3vh3XuhdQ'
2021-01-04,b'$BMY Bristol Myers Squibb to Present at J.P. Morgan\xe2\x80\x99s 39th Annual Virtual Healthcare Conference https://t.co/D5q1ZTo2gL'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'$BMY European Medicines Agency Validates Bristol Myers Squibb\xe2\x80\x99s Application for Opdivo (nivolumab) as Adjuvant Treatment for Resected Esophageal or Gastroesophageal Junction Cancer Following Chemoradiotherapy https://t.co/5alKfXvhWf'
2021-01-04,"b'$BMY European Medicines Agency Validates Bristol Myers Squibb\xe2\x80\x99s Application for Opdivo (nivolumab) Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma https://t.co/W7bhMsfPCx'"
2021-01-04,b'RT @BentheFidler: How an all-or-nothing bet on 3 Bristol Myers drugs came undone https://t.co/vnh3M6VaOR by @NedPagliarulo $BMYRT $BMY $CELG'
2021-01-04,"b'@DvdndDiplomats Small purchaches of $LMT, $NOC, $INTC, $ATO and $BMY'"
2021-01-04,"b'Today we buy $bmy, it is too cheap for the evolution expected  (3 years). The EV/EBITDA multiple is very low for its history and in this type of companies the re-rating is very rare https://t.co/EzAR0Q16WR'"
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @BentheFidler: How an all-or-nothing bet on 3 Bristol Myers drugs came undone https://t.co/vnh3M6VaOR by @NedPagliarulo $BMYRT $BMY $CELG'
2021-01-04,b'How an all-or-nothing bet on 3 Bristol Myers drugs came undone https://t.co/vnh3M6VaOR by @NedPagliarulo $BMYRT $BMY $CELG'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'$ABBV $APTV $BMY $DIS $HHC $INTC $LUV - 7 Cheap Stocks to Buy in January For a Quick Buck https://t.co/gqeYyFlEBO https://t.co/7nDleJ6NlY'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @IBD_AGatlin: #Biotech and #pharma news: $AZN is up on a report it will supply the U.K. with 2 million doses of its #Covid19Vaccine week\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'January 2021 Earnings \n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $GS $BLK $JNJ $T $PG $UNH $QCOM $KBH $ACI $VZ $MS $PNC $XOM $DHI $LOGI $CMC $CMG $XLNX $SJR $AZZ $BMY $CMA $CAT $SNX $FAST $INFY $MMM $EA $AA $ASML $MKC https://t.co/HkgEsKFwiq'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @UPBOptionMil: Today top stock option open interest changes $SNAP $NIO $BMY $INTC $TSLA $WBA $GM $CSCO https://t.co/mtZWAV1BXY'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'#WallStreet \xf0\x9f\x87\xba\xf0\x9f\x87\xb8 Most important #earnings for the next 30 days: \n\n$NFLX $INTC $PFE $EA $MMM \xf0\x9f\x94\x8d $BAC $TSM $GE $JPM $WFC $C $GS $BLK $JNJ $T $PG $UNH $QCOM $KBH $ACI $VZ $MS $PNC $XOM $DHI $CMC $CMG $XLNX $BMY $CMA $CAT $FAST $AA $MKC https://t.co/lkV94Yl9gN'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'$BMY European Medicines Agency Validates Bristol Myers Squibb\xe2\x80\x99s Application for Opdivo (nivolumab) as Adjuvant Treatment for Resected Esophageal or Gastroesophageal Junction Cancer Following Chemoradiotherapy | Business Wire https://t.co/WFrs4WfBZo'
2021-01-04,b'$BMY Bristol Myers Squibb to Present at J.P. Morgan\xe2\x80\x99s 39th Annual Virtual Healthcare Conference | Business Wire https://t.co/dQdTsVUMc8'
2021-01-04,"b""#Biotech and #pharma news: $AZN is up on a report it will supply the U.K. with 2 million doses of its #Covid19Vaccine weekly beginning in mid-January. Its vaccine also gained approval in India. The $BMY CVR is DOA after the FDA didn't approve liso-cel by Dec. 31."""
2021-01-04,"b'My next #OTC stock to RUN 1,000% to 5,000%+ EASY. See attached DD. \n\n$IVV $LQD $JD $XLI $WMT $VOO $XLV $DIS \n$CSCO $HD $PINS $PTON $FXI $GDX $QCOM $UAL $W $NOW $CCL $WFC $SLV $XLE $KCAC  $ROKU \n$LULU $SE $TSM $JNJ $KO $XLU $PG $XLP\n$TTD $LOW $BMY $XLY $XOM $TDOC $MELI\n$MU $FSLY https://t.co/jrvcSKEaQ0'"
2021-01-04,b'RT @MarcoDaCostaFX: #WallStreet \xf0\x9f\x87\xba\xf0\x9f\x87\xb8 Most important #earnings for the next 30 days: \n\n$NFLX $INTC $PFE $EA $MMM \xf0\x9f\x94\x8d $BAC $TSM $GE $JPM $WFC $C\xe2\x80\xa6'
2021-01-04,"b""$BMY Valuation Ratios vs Time_Instant metrics based on latest quarter's results annualized https://t.co/pgvmyJDCXR #PriceToEarnings #BMY https://t.co/d2Cs0a9I59"""
2021-01-04,b'$BLUE $EDIT $TBIO Top Biotech Buyout Candidates in 2021 @themotleyfool #stocks $TBIO $SNY $BMY $PFE $ABBV $BLUE $EDIT $MRNA $BNTX https://t.co/RaZidXkofp'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'some confirmed #earnings dates for the coming month\n\nhttps://t.co/YYhCWGJuZB \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $GS $BLK $JNJ $T $PG $UNH $QCOM $KBH $ACI $VZ $MS $PNC $XOM $DHI $LOGI $CMC $CMG $XLNX $SJR $AZZ $BMY $CMA $CAT $SNX $FAST $INFY $\xe2\x80\xa6 https://t.co/pOZLXU8dXK'
2021-01-04,b'RT @ChimeraResearch: January 4th Biotech Update $BMY $bmyrt $GILD $SGEN $XBI https://t.co/ykWdh7MhAM'
2021-01-04,b'RT @ChimeraResearch: January 4th Biotech Update $BMY $bmyrt $GILD $SGEN $XBI https://t.co/ykWdh7MhAM'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'January 4th Biotech Update $BMY $bmyrt $GILD $SGEN $XBI https://t.co/ykWdh7MhAM'
2021-01-04,b'$BMY Shares Outstanding vs time!  https://t.co/pgvmyJDCXR #Dilution #ButWorthIt #BMY https://t.co/vY0CVlpJGD'
2021-01-04,b'#WallStreet \xf0\x9f\x87\xba\xf0\x9f\x87\xb8 Most important #earnings for the next 30 days: \n\n$NFLX $INTC $PFE $EA $MMM \xf0\x9f\x94\x8d $BAC $TSM $GE $JPM $WFC $C $GS $BLK $JNJ $T $PG $UNH $QCOM $KBH $ACI $VZ $MS $PNC $XOM $DHI $CMC $CMG $XLNX $BMY $CMA $CAT $FAST $AA $MKC https://t.co/PHXhvVfXcN'
2021-01-04,b'#WallStreet \xf0\x9f\x87\xba\xf0\x9f\x87\xb8 Most important #earnings for the next 30 days: \n\n$NFLX $INTC $PFE $EA $MMM \xf0\x9f\x94\x8d $BAC $TSM $GE $JPM $WFC $C $GS $BLK $JNJ $T $PG $UNH $QCOM $KBH $ACI $VZ $MS $PNC $XOM $DHI $CMC $CMG $XLNX $BMY $CMA $CAT $FAST $AA $MKC https://t.co/8GvKdjtDtw'
2021-01-04,b'#WallStreet \xf0\x9f\x87\xba\xf0\x9f\x87\xb8 Most important #earnings for the next 30 days: \n\n$NFLX $INTC $PFE $EA $MMM \xf0\x9f\x94\x8d $BAC $TSM $GE $JPM $WFC $C $GS $BLK $JNJ $T $PG $UNH $QCOM $KBH $ACI $VZ $MS $PNC $XOM $DHI $CMC $CMG $XLNX $BMY $CMA $CAT $FAST $AA $MKC https://t.co/OGLTSbjxyY'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,"b""As of January 1, 2021, the FDA has not yet approved $BMY's #CD19 CAR-T liso-cel, and BMS's press release on January 1 confirmed the termination of the #Celgene CVR. Celltelligence provides insights: https://t.co/Dm0RxPWEOo https://t.co/KOwOFndjI8"""
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'$bmyrt $bmy notice of de listing \n\nhttps://t.co/INFXms052K'
2021-01-04,"b'My top 10 stock/ETF picks of 2021 (unordered)\n*=owned | \xe2\x80\xa2=looking for entry\n$AAPL *\n$AMZN \xe2\x80\xa2\n$ARKF \xe2\x80\xa2\n$AZEK *\n$BABA *\n$BMY \xe2\x80\xa2\n$FB *\n$NVDA *\n$SPCE *\nSeparately, I expect $BTC (#BTC) to at least double in 2021, as well. \nWhat are yours?'"
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'Recent $BMY technical alerts: MACD Bullish Signal Line Cross plus 4 more alerts... https://t.co/dWjqtrCIG0'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. US considers giving half-doses of Moderna vaccine; Americans may not get AstraZene\xe2\x80\xa6'
2021-01-04,b'Pharmalot.. Pharmalittle.. Good Morning.. US considers giving half-doses of Moderna vaccine; Americans may not get AstraZeneca shot until April &amp; more news.. https://t.co/lWYHyb5qnu #pharma #biotech #COVID19 #vaccine #coronavirus #opioids $AZN $MRNA $BMY $WMT $CALA $EXEL'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'$BMY Bristol-Myers Squibb Company SEC Filing: Form 25-NSE https://t.co/zwxZyLgytw'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'The weeks ahead... gonna be a fun ride\n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $GS $BLK $JNJ $T $PG $UNH $QCOM $KBH $ACI $VZ $MS $PNC $XOM $DHI $LOGI $CMC $CMG $XLNX $SJR $AZZ $BMY $CMA $CAT $SNX $FAST $INFY $MMM $EA $AA $ASML $MKC\n\nVia @eWhispers https://t.co/K57b8pnf6t'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,"b'A few key changes in open interest...\n\n$BMY - Feb $62.5 calls from 1,747 to 15,720 (+13,973)\n\n$NUAN - August $45 calls from 263 to 4,132 (+3,869)\n\n$SQ - Jan 29th $237.50 calls from 158 to 3,592 (+3,434)\n\n$WBA - Feb $40 calls from 673 to 1,807 (+12,134)'"
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-04,b'some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $GS $BLK $JNJ $T $PG $UNH $QCOM $KBH $ACI $VZ $MS $PNC $XOM $DHI $LOGI $CMC $CMG $XLNX $SJR $AZZ $BMY $CMA $CAT $SNX $FAST $INFY $MMM $EA $AA $ASML $MKC https://t.co/vnnyvffAtg'
2021-01-04,"b'$BMY MS maintains Overweight, PT 70'"
2021-01-04,b'RT @UPBOptionMil: Today top stock option open interest changes $SNAP $NIO $BMY $INTC $TSLA $WBA $GM $CSCO https://t.co/mtZWAV1BXY'
2021-01-04,b'I was told $bmy would be up 6. Illini in market cap after cvr failed bottom line everyone was wrong :)'
2021-01-04,b'RT @UPBOptionMil: Today top stock option open interest changes $SNAP $NIO $BMY $INTC $TSLA $WBA $GM $CSCO https://t.co/mtZWAV1BXY'
2021-01-04,b'RT @UPBOptionMil: Today top stock option open interest changes $SNAP $NIO $BMY $INTC $TSLA $WBA $GM $CSCO https://t.co/mtZWAV1BXY'
2021-01-04,b'Today top stock option open interest changes $SNAP $NIO $BMY $INTC $TSLA $WBA $GM $CSCO https://t.co/mtZWAV1BXY'
2021-01-04,"b""$BMY: Bristol-Myers: European Medicines Agency validates BMY's application for opdivo (nivolumab) combined with... https://t.co/WFLjODgxcP"""
2021-01-04,"b'OptionHacker alerted traders to bullish unusual option activity in 10 stocks Thursday including $BMY, $SLDB and  $LC.   Top performer was a same-day gain of 223% in $LC where January 9.0 calls bought for $0.55 closed at $1.77.'"
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,"b'When you see an 8-K from $BMY on the first day of the year, you open it rather hurriedly. What a letdown that one was.'"
2021-01-04,"b'$BMY #EMA Validates Bristol Myers Squibb\xe2\x80\x99S Application For Opdivo (Nivolumab) Combined With Chemotherapy As First-Line Treatment In Metastatic Gastric Cancer, Gastroesophageal Junction Cancer And Esophageal Adenocarcinoma'"
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'Bristol Myers Squibb call buyer realizes 25% same-day gains\n$BMY'
2021-01-04,b'$CVAC falls into BOTTOM TEN after brutal week.\n\nhttps://t.co/oqnENLGXM4\n\n$MRNA $NVAX $ARCT $BNTX $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP $PDSB $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT #pharma https://t.co/bDtvZEZabz'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,"b'RT @allezlombcit: $RSCF #nytimes 2020/12/31 #Covid_19 #SARS_CoV_2 #CovidVaccines #shipping $GILD $PFZ $BMY $JNJ $GSK \n#TheNewYorkTimes  ""We\xe2\x80\xa6'"
2021-01-04,b'$BMY Bristol-Myers Squibb Company SEC Filing: Form 8-K https://t.co/1QPMFSMNCM'
2021-01-04,b'Filing for 8-K [Press/News Current Report] has been made with the SEC:  $BMY $CELG.RI $BMY.RI BRISTOL MYERS SQUIBB CO  https://t.co/4VmigJx4aR'
2021-01-04,"b'$BMY / Bristol-Myers Squibb files form 8-K - Financial Statements and Exhibits, Other Events -  CURRENT REPORT https://t.co/EqWo77As8x'"
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,"b'$RSCF #nytimes 2020/12/31 #Covid_19 #SARS_CoV_2 #CovidVaccines #shipping $GILD $PFZ $BMY $JNJ $GSK \n#TheNewYorkTimes  ""We Came All This Way to Let #Vaccines Go Bad in the Freezer?""\nhttps://t.co/q65moz6X9v'"
2021-01-04,"b""$BMY Bristol Myers Squibb : European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo (nivolumab) as Adjuvant Treatment for Resected Esophageal or Gastroesophageal Junction Cancer Following Chemoradiotherapy"""
2021-01-04,"b""RT @TheStockWire: $BMY\nEuropean Medicines Agency Validates Bristol Myers Squibb's Application For Opdivo (nivolumab) As Adjuvant Treatment\xe2\x80\xa6"""
2021-01-04,"b""RT @quant_data: European Medicines Agency Validates Bristol Myers Squibb's Application For Opdivo Combined with Chemotherapy As First-Line\xe2\x80\xa6"""
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'$BMY Bristol Myers Squibb to Present at J.P. Morgan\xe2\x80\x99s 39th Annual Virtual Healthcare Conference https://t.co/PAvCWY93zp'
2021-01-04,"b""European Medicines Agency Validates Bristol Myers Squibb's Application For Opdivo Combined with Chemotherapy As First-Line Treatment In Metastatic Gastric Cancer, Gastroesophageal Junction Cancer And Esoph...\n\nRelated Tickers: $BMY\nRead more at: https://t.co/XjCfHTz27T"""
2021-01-04,"b""European Medicines Agency Validates Bristol Myers Squibb's Application For Opdivo (nivolumab) As Adjuvant Treatment for Resected Esophageal Or Gastroesophageal Junction Cancer Following Chemoradiotherapy\n\nRelated Tickers: $BMY\nRead more at: https://t.co/jKSA2JTEIq"""
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,"b""$BMY\nEuropean Medicines Agency Validates Bristol Myers Squibb's Application For Opdivo (nivolumab) As Adjuvant Treatment for Resected Esophageal Or Gastroesophageal Junction Cancer Following Chemoradiotherapy"""
2021-01-04,"b""EMA validates Bristol-Myers' application for Opdivo in GEJ cancer\n$BMY"""
2021-01-04,b'$BMY European Medicines Agency Validates Bristol Myers Squibb\xe2\x80\x99s Application for Opdivo (nivolumab) as Adjuvant Treatment for Resected Esophageal or Gastroesophageal Junction Cancer Following Chemoradiotherapy\nhttps://t.co/UhsThkp6dS\n\n#cancer'
2021-01-04,b'$BMY Bristol Myers Squibb - European Medicines Agency Validates Bristol Myers Squibb\xe2\x80\x99s Application for Opdivo\nFrom our Stock News Alerts App'
2021-01-04,b'$BMY Bristol Myers Squibb - Bristol Myers Squibb to Present at J.P. Morgan\xe2\x80\x99s 39th Annual Virtual Healthcare C\nFrom our Stock News Alerts App'
2021-01-04,b'$BMY Bristol Myers Squibb to Present at J.P. Morgan\xe2\x80\x99s 39th Annual Virtual Healthcare Conference\nhttps://t.co/MnfQAFlkoT'
2021-01-04,"b'$BMY European Medicines Agency Validates Bristol Myers Squibb\xe2\x80\x99s Application for Opdivo (nivolumab) Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma...\nhttps://t.co/JeRSWi6q7l\n\n#cancer'"
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'$BMY $SNY $TBIO - 3 Top Biotech Buyout Candidates in 2021 https://t.co/L52CI9BemH https://t.co/75tt0tmTOp'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @_B_I_O_T_E_C_H_: BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA h\xe2\x80\xa6'
2021-01-04,b'RT @StockMatusow: Calithera $CALA Biosciences: An Under The Radar Opportunity | $PFE $TRIL $EXEL $BMY $MRK $ESALF $GILD https://t.co/qd2IXH\xe2\x80\xa6'
2021-01-04,b'BAIRD Potential Deals We Could See Occurring in 2021\n$AMGN or $BMY  for $KPTI\nand $MRNA goes gene editing with $NTLA https://t.co/w5uWBcGi9U'
2021-01-04,"b'RT @stockmarkettile: Exelis is the Michelin of Biotech\n\n\xe2\x80\x9cTheir drug, cabozantinib, is part of many clinical trials and it\xe2\x80\x99s being tested ag\xe2\x80\xa6'"
2021-01-04,"b'Exelis is the Michelin of Biotech\n\n\xe2\x80\x9cTheir drug, cabozantinib, is part of many clinical trials and it\xe2\x80\x99s being tested against 15 types of cancer. So far, cabozantinib is present in over 100 ongoing and planned clinical trials.\xe2\x80\x9d\n\n$EXEL $IBB $XBI $BMY\nhttps://t.co/stKqxKOKAj'"
2021-01-04,b'Short sale vol (not short interest) for $BMY on 2020-12-31 is 51%. https://t.co/ZgrXNA0a1Z $MRK 33% $PFE 31% $SNY 53% $ABBV 56%'
2021-01-04,b'(5 Best Stocks To Buy - 2021-01-04 -  $CEF  $RVNC  $AMH  $BMY  $LEG) - https://t.co/S7cO8hGBd7 https://t.co/PiMJEA5C0N'
2021-01-04,"b""$BMY's price moved above its 50-day Moving Average on December 30, 2020. View odds for this and other indicators: https://t.co/foo8tcJS8n #Bristol #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5NFxz7wH7O"""
2021-01-04,b'RT @wyv_123: Reasonable chance we see same panic buying in biotech by big pharma who could have picked them up for cheap last 1-2 years but\xe2\x80\xa6'
2021-01-04,b'RT @SergDJB: $BMY for a swing here at support level. Leaps are pretty cheap for the potential move with strong support and SL \xf0\x9f\x9b\x91 below the y\xe2\x80\xa6'
2021-01-04,b'RT @SergDJB: $BMY for a swing here at support level. Leaps are pretty cheap for the potential move with strong support and SL \xf0\x9f\x9b\x91 below the y\xe2\x80\xa6'
2021-01-04,b'$BMY for a swing here at support level. Leaps are pretty cheap for the potential move with strong support and SL \xf0\x9f\x9b\x91 below the yellow\xe2\x9a\xa0 $AMD $SPY $INTC $BABA $TSLA $LOW $FB $SQ $QQQ $FSLY $ZM $PTON $AAPL $BA $JNJ $NIO $TWTR $MSFT $QCOM $SPCE $ATVI $TMUS $BAC $PINS $CGC $TWLO $SNAP https://t.co/kr0BbxMvKo'
2021-01-04,b'RT @DavisTrades: New video breaking down the charts and option flow on: $ZM $BMY $ABNB $APPN $TGT\n\nLink below. Check it out.\xf0\x9f\x91\x8a\n\nhttps://t.co\xe2\x80\xa6'
2021-01-04,b'$BMY\n\nTop 5 pick for 2021 https://t.co/onm74tjbAT'
2021-01-04,b'RT @wyv_123: Reasonable chance we see same panic buying in biotech by big pharma who could have picked them up for cheap last 1-2 years but\xe2\x80\xa6'
2021-01-04,b'Reasonable chance we see same panic buying in biotech by big pharma who could have picked them up for cheap last 1-2 years but now will have to FOMO pay up. $XBI $TRIL $EDIT $CRIS $TCON $MREO $SGMO $PFE $BMY $MRK $LLY https://t.co/xVvXf12Uki'
2021-01-03,"b'$BLUE $43.27 -0.84  -1.90%ide-cel bb2121 - KarMMa\nRelapsed/refractory multiple myeloma PDUFA date under priority review March 27, 2021.\n$BMY $62.03 +0.60  +0.98%ide-cel bb2121 - KarMMa\nRelapsed/refractory multiple myeloma\nPDUFA date under priority review March 27, 2021.'"
2021-01-03,b'$BMY $62.03 +0.60  +0.98%CABOMETYX cabozantinib) with Opdivo and Yervoy - CheckMate 9ER\nFirst-line renal cell carcinomaPDUFA priority review\n02/20/2021 PDUFA date under priority review.'
2021-01-03,"b'@Rick_Ferri @stuckonHX I love cash flow producing assets. I own a whole bunch of $CVS, $BMY, $PEP, $TGT, $PG, $MDT etc etc etc\n\nI also own real estate and Bitcoin.\n \nBitcoin is outperforming everything by a huge margin.'"
2021-01-03,"b'$BMY\n$62.03\n+0.60  +0.98%liso-cel (JCAR017)\nRelapsed or refractory (R/R) large B-cell lymphomaPDUFA priority review\nDecision deferred by FDA\nPDUFA date under priority review scheduled for November 16, 2020 has been delayed as the FDA was'"
2021-01-03,b'2020-12-31 Short sale volume (not short interest) for $ABBV is 56%. https://t.co/yR4dSlG9rp $LLY 56% $BMY 51% $PFE 31% $XLV 60%'
2021-01-03,b'Bristol-Myers provides update on status of Contingent Value Rights \n$BMY'
2021-01-03,b'$BMY Implied Volatility expiration 01/08/2021 #maxpain #options https://t.co/MVlqhqX47j https://t.co/wbqufHh98k'
2021-01-03,b'RT @GrowthDividend: Final Top-5 of the year 2020:\n\nMy undervalued quality dividend stocks Top 5 list this week:\n\n1. $MRK\n2. $GD\n3. $INTC\n4.\xe2\x80\xa6'
2021-01-03,b'RT @DavisTrades: New video breaking down the charts and option flow on: $ZM $BMY $ABNB $APPN $TGT\n\nLink below. Check it out.\xf0\x9f\x91\x8a\n\nhttps://t.co\xe2\x80\xa6'
2021-01-03,b'RT @DavisTrades: New video breaking down the charts and option flow on: $ZM $BMY $ABNB $APPN $TGT\n\nLink below. Check it out.\xf0\x9f\x91\x8a\n\nhttps://t.co\xe2\x80\xa6'
2021-01-03,b'New video breaking down the charts and option flow on: $ZM $BMY $ABNB $APPN $TGT\n\nLink below. Check it out.\xf0\x9f\x91\x8a\n\nhttps://t.co/Kl9b3DOgkN https://t.co/Sygps9maTo'
2021-01-03,"b""Warren Buffett's 3 Best Stock Picks in 2020 @themotleyfool #stocks $BAC $BRK-A $BRK-B $BMY https://t.co/X9E9sFLcRJ"""
2021-01-03,b'$BMY Financial metrics; presented on per share basis https://t.co/pgvmyJDCXR #PerShare #BMY https://t.co/WvUhvaEjQz'
2021-01-03,"b""Warren Buffett's 3 Best Stock Picks in 2020 @themotleyfool #stocks $BAC $BRK-A $BRK-B $BMY https://t.co/YMKMFi789R"""
2021-01-03,b'@lblegend33 $BMY rerating'
2021-01-03,"b'Let\xe2\x80\x99s start the year 2021!\n\nMy undervalued quality #dividend stocks Top 5 list this week:\n\n1. $MRK\n2. $GD\n3. $INTC\n4. $LMT\n5. $BMY\n\nTo be part of this list the stock should be at least 10% below my fair value, payout ratio of &lt;60% and yield 2% or more (exceptions allowed)'"
2021-01-03,b'@GerberKawasaki Last question: are healthcare stocks actually values in 2021 or are these just bull traps \xf0\x9f\x91\x80\n\n$regn\n$mrk\n$gsk\n$bmy\n$abbv'
2021-01-03,"b""RT @sentimentstock: While $BMY's Opdivo calls it quits for their newly diagnosed methylated #GBM trial... only $NWBO's #DCVax  (for which t\xe2\x80\xa6"""
2021-01-03,"b""CVR tied to BMS's Celgene takeover slips away as key deadline passes https://t.co/sERm7Xuo6Q $BMY"""
2021-01-03,"b""Warren Buffett's 3 Best Stock Picks in 2020 @themotleyfool #stocks $BAC $BRK-A $BRK-B $BMY https://t.co/pu1n9bBg59"""
2021-01-03,"b""Warren Buffett's 3 Best Stock Picks in 2020 @themotleyfool #stocks $BAC $BRK-A $BRK-B $BMY https://t.co/YxB8uqrryg"""
2021-01-03,"b'@European_DGI My favorites that I already own are $AVGO (insane growth) and $BMY (quadruppled div hikes since last year). Strong div growers that I pursue in 2021 include $HD / $LOW, $MA / $V, $ABT / $BDX, $ASML and $ROP. Winner based on only 1 yr or 5 yr growth?'"
2021-01-03,b'2020-12-31 Short sale volume (not short interest) for $SVXY is 48%. https://t.co/G7GRAx8hYl $RRC 57% $CCJ 59% $COTY 35% $BMY 51%'
2021-01-03,b'Short sale vol (not short interest) for $KPTI on 2020-12-31 is 43%. https://t.co/FLF4COeUQj $MRK 33% $ABT 36% $BMY 51%'
2021-01-03,"b""$BMY's price moved above its 50-day Moving Average on December 30, 2020. View odds for this and other indicators: https://t.co/46dCTWIcA9 #Bristol #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/yrBd604OZM"""
2021-01-03,b'@lowreturns @semodough $AMGN acquired a $2B drug Otezla from $BMY at $13.4B (x6) well knowing that BMY have a drug in the pipeline which could be approved in less than 5 years and wipe out Otezla. So I am using a x6 multiple for a buyout scenario. \n\nhttps://t.co/hvScb9AsS1'
2021-01-03,b'$BMY $NIO $IQ $IBB $TSLA been using this data to make some nice trades. https://t.co/zRpyCqFCHu'
2021-01-03,"b'LR - amazing stat Immunology market est $83bn in 2020, with rheumatoid arthritis, psoriasis, and Crohn\xe2\x80\x99s disease as largest contributors\nTotal immunology market grew at 8% CAGR 2017-2020E $REGN $BMY $XBI'"
2021-01-03,b'$RDAR Confirmation Coming On Secret Reverse Merger Discussions Underway In Nevada\nhttps://t.co/Mv3xmUJu9A\n\n$MRO $KEY $BMY $FNRC $TXTM $ABVG $SHMN $LDSI $HMNY $INPX $IBN $M $SING'
2021-01-03,b'RT @BiotechObserver: I bet you that Lisocel gets approved on Monday.  Never bet on FDA.  Never trust a CVR that involves betting on FDA.  $\xe2\x80\xa6'
2021-01-02,"b""@purpledank_64 $LAZR looks great. $BMY in a fresh #ActSeq, but I'm not sure how much room it has to climb"""
2021-01-02,b'RT @EmergingGrowth1: $RSPI RespireRx Pharmaceuticals Inc. (RSPI) Announces $2 Million Funding Commitment\n\nhttps://t.co/Ba6Iukhqzq\n\n$CYDY $A\xe2\x80\xa6'
2021-01-02,b'I bet you that Lisocel gets approved on Monday.  Never bet on FDA.  Never trust a CVR that involves betting on FDA.  $BMYRT $BMY @US_FDA @SteveFDA CBER'
2021-01-02,b'@sevencornerscap @AppleHelix Yes. BMS PR. $BMY $BMYRT https://t.co/QR7uKbLLG4'
2021-01-02,b'@DavisTrades $bmy please!'
2021-01-02,b'RT @purpledank_64: @DavisTrades looks good! Check out $BMY and $LAZR both are about to explode!!'
2021-01-02,b'Calithera $CALA Biosciences: An Under The Radar Opportunity | $PFE $TRIL $EXEL $BMY $MRK $ESALF $GILD https://t.co/qd2IXH98J9 #KidneyCancer #LungCancer #Biotech #Stocks #StockMarket #ASCO #KEAP1 #NRF2 #CancerResearch #Cancer #Genitourinarycancers'
2021-01-02,b'@ChartingOptions Hey you definitely want to check out $LAZR $BMY they both offer good pennant setups you like with the 21/8 crossing over + decent volume!!'
2021-01-02,b'RT @AaronR0th: $AMD $AAPL $BMY Game Plans https://t.co/Zu9gVE7X9z'
2021-01-02,b'@DavisTrades looks good! Check out $BMY and $LAZR both are about to explode!!'
2021-01-02,b'RT @BullishJason: Who wants a chart done ahead of the the first trading day of 2021??\n\nComment ONE symbol for me to chart on @TrendSpider\xe2\x80\xa6'
2021-01-02,b'RT @BullishJason: Who wants a chart done ahead of the the first trading day of 2021??\n\nComment ONE symbol for me to chart on @TrendSpider\xe2\x80\xa6'
2021-01-02,"b'$BMY - heavy call volume this week, with a nice looking chart, now above the most frequently traded recent prices. I took a starter, $59.50 stop. News out after the bell that pharma companies raising prices. \n\nNice looking rounded base on the chart. Will add on strength https://t.co/gWANOartZJ'"
2021-01-02,"b'RT @pharris667: $BMY Bristol-Myers Squibb discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. FE\xe2\x80\xa6'"
2021-01-02,"b'$BMY Bristol-Myers Squibb discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. FEB 62.5 calls Being Traded in the Options Market as it trends the 50 Day Moving Average https://t.co/WVxmJ4JmWI'"
2021-01-02,b'RT @jq1234t: 1Q21 Catalysts:\n\n$AGIO Mitapivat Transfusion Dependent PKD ph3\n$BMRN Valrox Hemophilia A ph3\n$BMY Relatlimab(anti-LAG3) 1L Mel\xe2\x80\xa6'
2021-01-02,"b""Current Forward PE's:\n\n$BMY: 8.31\n$KO: 25.92\n$GE: 29.11\n$JNJ: 17.50\n$PG: 23.48\n$WMT: 25.05"""
2021-01-02,"b'Check out the PE\xe2\x80\x99s on $BMY, $KO, $GE, $JNJ, $PG and $WMT. \n\nThose companies traded like growth stocks. https://t.co/FPydS9TaXO'"
2021-01-02,b'RT @Biotech2050: #biopick2021 deadline is today. Come in and participate . Please RT. $SGMO $ZIOP $PGEN $TGTX $BMYRT $BMY $ACAD $IBB $XBI $\xe2\x80\xa6'
2021-01-02,b'RT @stockassassin74: Huge positions into new year $aapl $dis $pins $gild $biib $nvax $bmy $alxn'
2021-01-02,"b'$BMY technical alerts: MACD Bullish Signal Line Cross, 50 DMA Support, Bollinger Band Squeeze, and... https://t.co/dWjqtrCIG0'"
2021-01-02,b'RT @stevenhead211: @JohnCendpts $bmy is the most undervalued bio pharma out there. \nStock will benefit significantly from celg BO \nI see 99\xe2\x80\xa6'
2021-01-02,b'RT @1stOncology: #BristolMyersSquibb Reported Fda Has Not Provided A New Action Date For This Application For The Ongoing Review Of The #BL\xe2\x80\xa6'
2021-01-02,b'#BristolMyersSquibb Reported Fda Has Not Provided A New Action Date For This Application For The Ongoing Review Of The #BLA For #LisoCel $BMY https://t.co/QUUkzMBBg0'
2021-01-02,"b'#biopick2021 deadline is today. Come in and participate . Please RT. $SGMO $ZIOP $PGEN $TGTX $BMYRT $BMY $ACAD $IBB $XBI $KPTI $CRMD $ATNM $XLRN ...., $.... https://t.co/YDkAei1mGp'"
2021-01-02,b'RT @jq1234t: 1Q21 Catalysts:\n\n$AGIO Mitapivat Transfusion Dependent PKD ph3\n$BMRN Valrox Hemophilia A ph3\n$BMY Relatlimab(anti-LAG3) 1L Mel\xe2\x80\xa6'
2021-01-02,"b'RT @DewDiligence: @bradloncar 1 $RVNC receives ~$5B buyout offer, which might not be accepted.\n2 $ENTA gets out of penalty box by making pr\xe2\x80\xa6'"
2021-01-02,"b'my biotech holdings on 12/31/2020 are: $CRIS $EXEL $MREO $NBIX $ONCT $SIOX $TCON $CRDF $KPTI $TRIL $VKTX $ALXN , will add $INCY and $ALXO when market opens in the new year. Also holding $BMY and $ABBV.'"
2021-01-02,b'Who wants a chart done ahead of the the first trading day of 2021??\n\nComment ONE symbol for me to chart on @TrendSpider \n\n$AAPL $MSFT $AMZN $FB $NFLX $NVDA $TSLA $GOOGL $QQQ $SPY $DIA $AMD $ZM $BYND $BA $BABA $DAL $WMT $HD $GS $COST $MA $WORK $SHOP $BMY $XLF $XLK $PG $DKNG $TLRY'
2021-01-02,"b'Also, interestingly, many of these were also Nifty Fifty names:  $ko $bmy $pfe $mo $jnj etc'"
2021-01-02,b'RT @ChrisBloomstran: $BRK has gone on drugs! $ABBV $BMY $MRK $PFE!!!'
2021-01-02,b'RT @jq1234t: 1Q21 Catalysts:\n\n$AGIO Mitapivat Transfusion Dependent PKD ph3\n$BMRN Valrox Hemophilia A ph3\n$BMY Relatlimab(anti-LAG3) 1L Mel\xe2\x80\xa6'
2021-01-02,"b'@WestlakeEquit Who is the \xe2\x80\x9cnew issued\xe2\x80\x9d\nsecurity sponsor? Anytime there is a termination event on a derivative that is listed, it can\xe2\x80\x99t be traded unless buyer and seller agree on the terms of the transaction AND there is a financial sponsor. $BMY already said they are out so it\xe2\x80\x99s now a claim.'"
2021-01-02,b'$BMY was analyzed by 16 analysts. The buy consensus is at 84%. So analysts seem to be very confident about $BMY. https://t.co/eG6NW31WQq https://t.co/jqS1m8oH4u'
2021-01-02,b'2020-12-31 Short sale volume (not short interest) for $KPTI is 43%. https://t.co/FLF4COeUQj $BMY 51% $MRK 33% $ABT 36%'
2021-01-02,"b'My buys for 1/4: $GE, $ICLN, $KO, $PRU, $ADM, $GM, $CVS, $BMY, $VT'"
2021-01-01,"b'@GuptaBioDD $BMYRT\n\nAgree that $CELG could/should have negotiated a better CVR Agreement (if it was going to use a CVR at all).\n\nAs is (or was), CVR payout was akin to hitting on a box trifecta. \n\nThat said, $BMY could be under some scrutiny for FDA submission and/or alacrity of followup.'"
2021-01-01,b'RT @jq1234t: 1Q21 Catalysts:\n\n$AGIO Mitapivat Transfusion Dependent PKD ph3\n$BMRN Valrox Hemophilia A ph3\n$BMY Relatlimab(anti-LAG3) 1L Mel\xe2\x80\xa6'
2021-01-01,b'RT @sunrgu: $BMY saved money and have PARP combo data on hand. Can they buy $CLVS .'
2021-01-01,b'SweepCast observed yesterday: $BMY Bristol-Myers Squibb Option Alert: Feb 19 $62.5 Calls Sweep \xf0\x9f\x90\x82 | Try https://t.co/GA7fZBDRYw today! \xf0\x9f\x98\x8e |#newyear #nye #stonks #daytraders #cnbc #cramer https://t.co/6LVOc2gc9V'
2021-01-01,b'@jq1234t No guidance but we may get Rucca+Opidivo combo data $CLVS $BMY'
2021-01-01,b'$BMY saved money and have PARP combo data on hand. Can they buy $CLVS .'
2021-01-01,"b'RT @TheMightyForego: $BMY, $BMYRT, news comes as little surprise...but every contract has implied covenant of good faith &amp; fair dealing so.\xe2\x80\xa6'"
2021-01-01,"b'@jq1234t @Ogut_Ozgur To the best of my knowledge, there is no public info about misdeed by $BMY\nBut\nIn a trial, during discovery much info come to light\nWill it be sufficient? I do not know but worth a try'"
2021-01-01,"b'RT @ScripMandy: No FDA decision on the liso-cel BLA by Dec. 31 and no new PDUFA date assigned to the application, so it should come as no s\xe2\x80\xa6'"
2021-01-01,"b'@WallStJesus This is related to the expiration of the $6.4B Celgene buyout sweetener that expired on Dec 31, 2020, due to unfulfilled terms.  A big plus for $BMY because it no longer has a $6.4B obligation as of the last 2020 trading day.  Stock potentially can jump 4% on Monday.'"
2021-01-01,b'RT @jq1234t: 1Q21 Catalysts:\n\n$AGIO Mitapivat Transfusion Dependent PKD ph3\n$BMRN Valrox Hemophilia A ph3\n$BMY Relatlimab(anti-LAG3) 1L Mel\xe2\x80\xa6'
2021-01-01,b'RT @jq1234t: 1Q21 Catalysts:\n\n$AGIO Mitapivat Transfusion Dependent PKD ph3\n$BMRN Valrox Hemophilia A ph3\n$BMY Relatlimab(anti-LAG3) 1L Mel\xe2\x80\xa6'
2021-01-01,b'1Q21 Catalysts:\n\n$AGIO Mitapivat Transfusion Dependent PKD ph3\n$BMRN Valrox Hemophilia A ph3\n$BMY Relatlimab(anti-LAG3) 1L Melanoma ph3\n$NVS Iptacopan(Factor B) IgAN ph2\n$SRPT SRP-9001 DMD ph2\n$SNDX-5613 MLL-r/NPM1 AML ph1\n\nCovid-19 Vaccine:\n$AZN US ph3\n$JNJ US ph3\n$NVAX UK ph3 https://t.co/GvakdEQgNI'
2021-01-01,b'@PersimmonTI What about $BMY? Freed up $6Bn now that CVR is dead.'
2021-01-01,b'$BMY Shares Outstanding vs time!  https://t.co/pgvmyJDCXR #Dilution #ButWorthIt #BMY https://t.co/g2kVVq6sfN'
2021-01-01,b'$DNMR - For those not convinced that 100% Marine Biodegradable Plastic will save more lives in the next century than all of $MRK $BMY and $AZA checkpoint inhibitors - here is the worldwide effort that says it\xe2\x80\x99s so: https://t.co/oRj7wrNksk'
2021-01-01,"b'The headline ""Bristol-Myers Derivative Is Now Worthless as Key Deadline Passes"" is obviously utter nonsense (litigation value, possibility of a ""voluntary tender offer"", etc), but hey, what does #bloomberg know about @business stuff :) $BMYRT $BMY https://t.co/HQ0XvfR3mX'"
2021-01-01,b'@ndrewColburn Buy $bmy'
2021-01-01,b'@Ogut_Ozgur I would rather see $BMY implement a 1 time dividend payment of 3.98/share which would equal 9b in distributions.'
2021-01-01,"b'RT @DewDiligence: @bradloncar 1 $RVNC receives ~$5B buyout offer, which might not be accepted.\n2 $ENTA gets out of penalty box by making pr\xe2\x80\xa6'"
2021-01-01,"b'RT @DewDiligence: @bradloncar 1 $RVNC receives ~$5B buyout offer, which might not be accepted.\n2 $ENTA gets out of penalty box by making pr\xe2\x80\xa6'"
2021-01-01,"b'@bradloncar 1 $RVNC receives ~$5B buyout offer, which might not be accepted.\n2 $ENTA gets out of penalty box by making progress in RSV &amp;/or HBV.\n3 $ABT continues 2b a great stock.\n4 $PFE gains favor for Prevnar-20 prgrm.\n5 $BMY does well b/c stock is dirt cheap.\n6 $ICPT continues 2b dead $.'"
2021-01-01,b'$BMY Bristol-Myers Derivative Is Now Worthless as Key Deadline Passes\n\nhttps://t.co/3mEfTexyYc'
2021-01-01,b'RT @adamfeuerstein: $BMY statement on the Celgene CVR $BMYRT. Terminated. \n\nhttps://t.co/F9F2tbSGQo'
2021-01-01,b'@Ogut_Ozgur $bmy had to refile $blue and delay for Juno as well\n\nhttps://t.co/rArgO8tBUM\n\nhttps://t.co/taCEVZwPyp'
2021-01-01,"b""@cablecarcapital @Biohazard3737 I may buy it under 0.5 thinking $BMY might payout 10 cents on the dollar just to avoid discovery. Why risk something coming to light that may paint the initial RTF as due to inexcusable blunder.\n\nNo position as of yet, but I've traded it several times.\n\n$BMYRT"""
2021-01-01,b'(Although the post-Lonza thesis that FDA &amp; $BMY had an incentive to get it done by year end was flawed imo)'
2021-01-01,b'Are $bmyrt holders going to litigate simply because they lost money? Or has there been a revelation that I missed wrt $BMY\xe2\x80\x99s conduct?'
2021-01-01,"b'@lattice1234 @given2tweet @cablecarcapital Yes. If major amendment and RTF have a common root cause (major systematic deficiencies in both application), there\xe2\x80\x99ll probably be a good case. Liso-cel BLA happened under $BMY and they also inherit their legal liabilities.'"
2021-01-01,"b""@given2tweet @cablecarcapital The amount of settlement I understand is a reflection of the strength of the case that the lawyers come up with. The repeated pattern of delays from $BMY's milestone related submissions (lisocel MA/Idecel RTF/483 responses)  vs scant history of MA/RTF otherwise hopefully matters"""
2021-01-01,b'$BMY Reveals Status of Contingent Value Rights       #BristolMyersSquibb     https://t.co/QUHIvzU5aD'
2021-01-01,"b'@cablecarcapital The major amendment delay of 3 months for Liso-cel, information requests after 483 responses, RTF 3 month delay for ide-cel, things not usually associated with other $BMY FDA submissions - will those matter?'"
2021-01-01,"b'$BMY sweet, just save $6.4B on not having to pay the CVR.'"
2021-01-01,"b""@JohnCendpts Isn't this bullish for $bmy stock?"""
2021-01-01,b'@ScripMandy Is this good or bad for $bmy stock?'
2021-01-01,"b""@kvanderlay1 @tonythearena $BMY put out a statement this morning saying that trading has ceased on the CVR. Since there was a deadline of 12/31/20 I'm pretty certain the loss occurred at 12:01am on 1/1/21."""
2021-01-01,"b'No FDA decision on the liso-cel BLA by Dec. 31 and no new PDUFA date assigned to the application, so it should come as no surprise that the $9/share contingent value right $BMY owed $CELG shareholders is terminated. Trading of the CVR has $BMYRT has ended. https://t.co/EaI5UYoVay'"
2021-01-01,b'$bmy $bmyrt https://t.co/1xMyEvpN2C'
2021-01-01,"b'@cperruna I usually do too, but I like the idea of biotech software for future drug discoveries.  $BMY signed a deal with them with ""performance"" compensation. Faster, cheaper R&amp;D for drug discovery I believe the potential is there, and may be worthy of a look. I do own.'"
2021-01-01,"b'I am still struggling to see which specific combo would be interesting with Pfizer? Ibrance? Clinical trial info show Opdivo from $BMY as potential combo, and Opdivo is a big block buster too.'"
2021-01-01,b'RT @stevenhead211: @JohnCendpts $bmy is the most undervalued bio pharma out there. \nStock will benefit significantly from celg BO \nI see 99\xe2\x80\xa6'
2021-01-01,b'RT @stevenhead211: @JohnCendpts $bmy is the most undervalued bio pharma out there. \nStock will benefit significantly from celg BO \nI see 99\xe2\x80\xa6'
2021-01-01,"b""Well played #BristolMyers.\nCompleting ~95% of the path towards #FDA approving all 3 #Celgene's drugs, yet paying nothing to old $CELG shareholders who now hold CVRs with an economic value of circa $9B, and a #market value of 0.\n$BMY $BMY.RT #Health #Healthcare $XLV https://t.co/8amxnU5T6J"""
2021-01-01,"b'@JohnCendpts With no payout on the CVR (BMYRT), $BMY saves $6.3B or $2.80 for every BMY share.'"
2021-01-08,b'$SPOT 10.15 -&gt; 18.96 \xf0\x9f\x94\xa5\n$BIDU 9.65 -&gt; 16.00 \xf0\x9f\x9a\x80\n\nHuge wins for the server to close the week! \n\nFree 3-Day-Trial in my bio!\n\n$AAPL $MSFT $AMZN $FB $NFLX $NVDA $TSLA $GOOGL $QQQ $SPY $DIA $AMD $ZM $BYND $BA $BABA $DAL $WMT $HD $GS $COST $MA $WORK $SHOP $BMY $XLF $XLK $PG $DKNG $TLRY https://t.co/qpC72AflBo'
2021-01-08,"b'@SquawkStreet @davidfaber Patent No. 10,328,093 titled ""Anthracycline Formulations,""reconstituted formula of aldoxorubicin that stabilizes &amp; solubilizes it in ethanol &amp; water -eliminates the need for cold handling, allowing administer to cancer patients at room temperature. $BMY'"
2021-01-08,b'RT @eWhispers: some confirmed #earnings dates for the coming month\n\nhttps://t.co/lObOE0dgsr \n\n$NFLX $INTC $PFE $BAC $TSM $GE $JPM $WFC $C $\xe2\x80\xa6'
2021-01-08,b'Scan results - MACD Bullish Centerline Cross today: $APDN $SNDR $SJR $MDLA $IFF $AWK $INOV $CVM $ROOT $BDTX $ATCO $ES $SO $GLW $NLS $TNK $WCN $BMY $WM $DKNG ... https://t.co/uZD9TkkAtC'
2021-01-08,"b""Glad This Didn't Happen in 2020. Will $SRPT Fall Back To $50?\n\n$aapl $amzn $abbv $bhc $brk $ba $crm $cmg $dis $f $ge $gm $iep $msft $nflx $ms $gs $wfc $jpm $bac $c $cs $hlf $ibm $pep $wmt $tgt $kr $btc $tst $googl $tsla $qsr $dal $luv $sbux $nke $ual $bmy $lly $azn $pfe $teva https://t.co/TsgkzaRBCN"""
2021-01-08,"b'Breakeven day. Took some profits and opened a few new positions for next week. Added more $AMRN 6c for 22 Jan playing the JPM conference and 10c for Jan 22 for a bullish year recovery.  $PINS Feb 55c, $AMZN 3170/3200/3230c fly for next week, and added some more $BMY Feb 62.50'"
2021-01-08,"b""Friday's Top Flow in #healthcare sector, Buy Flow &amp; Sell Flow $CERN $ABC $MRK $ABT $LLY $XRAY $BDX $ABBV $MCK $GILD $ISRG $ALXN $VAR $BMY $UNH $PKI $JNJ $DGX $TMO $BSX #stock #stocks #StockMarket #Investment #investing #HealthTech https://t.co/5JE2nlrW3B https://t.co/uQggsB4uFa"""
2021-01-08,"b'$BMY Rising Price, Declining Volume\nDaily appearances since 2010: 88\nClose 5 days later \xc2\xb1:\nAvg: 0.16\nSD: 1.43\nWorst: -3.99\nBest: 4.46\n\n10 days later:\nAvg: 0.51\nSD: 2.02\nWorst: -5.40\nBest: 4.97\n\n30 days later:\nAvg: 0.47\nSD: 4.46\nWorst: -18.01\nBest: 8.49'"
2021-01-08,b'$BMY Three White Soldiers\nDaily appearances since 2010: 32\nClose 5 days later \xc2\xb1:\nAvg: 0.34\nSD: 1.50\nWorst: -4.10\nBest: 6.29\n\n10 days later:\nAvg: 0.53\nSD: 2.06\nWorst: -3.53\nBest: 5.74\n\n30 days later:\nAvg: 0.61\nSD: 2.90\nWorst: -7.52\nBest: 8.02'
2021-01-08,b'$BMY Inverted Hammer\nDaily appearances since 2010: 63\nClose 5 days later \xc2\xb1:\nAvg: 0.16\nSD: 1.86\nWorst: -4.54\nBest: 6.29\n\n10 days later:\nAvg: 0.15\nSD: 2.49\nWorst: -6.01\nBest: 8.90\n\n30 days later:\nAvg: 0.01\nSD: 4.96\nWorst: -14.47\nBest: 11.69'
2021-01-08,b'$BMY Revenue and Earnings growth rates vs time; one plot.  https://t.co/pgvmyJDCXR #TheMoreYouKnow #BMY https://t.co/emJkxXG5Lq'
2021-01-08,b'$BMY Margins vs Time!  https://t.co/pgvmyJDCXR #CashCow #BMY https://t.co/laEwm7mzNt'
2021-01-08,b'$ISR with this huge FDA NEWS $3 break is eminent but what if it breaks $15?\xf0\x9f\x92\xb8\n\n$THOR $XBIT $ARQL $FATE $ACHV $OBSV $AGIO $ABEO $RCKT $DTIL $AM $CGC $SESN $SGMO $BMY $GALT $DD $DPLO $THO $JT $JNJ $PFE $LLY $MRK $ROKU $TSLA $FB $MU $SIRI $SPY $UBER $AMZN $JPM #CRYPTO #BITCOIN $F $C https://t.co/uO0IYlTUyz'
2021-01-08,"b'RT @Dividend_Dollar: Pharmaceuticals/Healthcare stocks are a great place to find growth, stability, and solid dividends\n\n$5K invested in EA\xe2\x80\xa6'"
2021-01-08,b'Paul Torres-Cohen $BMY'
2021-01-08,b'@RNAiAnalyst $RNA certainly looks a lot more interesting now... they just announce a collaboration with $BMY today https://t.co/eyrjVf3VII'
2021-01-08,"b'$SHWZ $1.79-Annotated chart shows it\'s ""RUNNING the UPPER BOLLINGER"" band - Colorado Marijuana - Acquired STARBUDS and Mesa Organics with more to come.  $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS $WBA $RAD $HLF $CJJD $GNC https://t.co/2712F4sdmB'"
2021-01-08,"b'RT @jodigralnick: TUNE IN: #JPM21 is almost here! As always, @CNBCnow has a stellar, all-exclusive lineup. CEOs of $BNTX $GILD $ILMN $BMY $\xe2\x80\xa6'"
2021-01-08,"b'RT @sharpie510: When the $nwbo adcom arrives, you can be assured there will be many influential #glioblastoma patient advocates like Dr. Mu\xe2\x80\xa6'"
2021-01-08,"b'Large Print $BMY Size: 114846 Price: 62.85 Time: 1206 Amount: $7,218,071.10'"
2021-01-08,b'@jimcramer How about $BMY Jim? Thanks all your help.'
2021-01-08,b'Up and Down the Ladder: Job Changes.. the latest comings &amp; goings.. recognize anyone? lots of names.. https://t.co/kvQP29YPco #pharma #jobs $MRNA $AMGN $BMY $CVS $MOR $PFE $EQ $CMPI $NVAX $ENTA $CNST $TARS $SAVA $OBSV $PRTC $LOGC $CYCN $PLRX $PACB $ELTP $EVLO $MYOV $QPEX $NKTR'
2021-01-08,b'@jimcramer I\xe2\x80\x99ve got my $BMY with the dividends reinvested!'
2021-01-08,"b'@mcuban @davidfaber @jimcramer \nOn January 5, 2021, CytRx Corporation entered into a new Employment Agreement with John Y. Caloz Chief Financial Officer, Mr. Caloz is entitled to a base annual salary of $400,000. $CYTR $NK $BMY Dr. Patrick Soon Shioing, Aldoxorubicin vs Abraxane'"
2021-01-08,b'$BMY BULL FLOW'
2021-01-08,b'RT @LukeDonay: Watchlist time! \xf0\x9f\x91\x87\n\n\xf0\x9f\x91\x9a $LULU\n\xf0\x9f\x92\xb0 $SQ  $PYPL\n\xf0\x9f\x92\xb3 $V\n\xe2\x9c\x88\xef\xb8\x8f $BA\n\xf0\x9f\x9b\x92 $WMT $COST\n\xf0\x9f\x8e\xae $AMD $NVDA\n\xf0\x9f\x91\x9f $NKE\n\xf0\x9f\x92\xbc $CRM\n\xf0\x9f\x94\x8d $GOOGL\n\xf0\x9f\x9a\x91 $TDOC\n\xe2\x9c\x8f\xef\xb8\x8f $CHGG\n\xe2\x98\x95 $SBU\xe2\x80\xa6'
2021-01-08,b'Watchlist time! \xf0\x9f\x91\x87\n\n\xf0\x9f\x91\x9a $LULU\n\xf0\x9f\x92\xb0 $SQ  $PYPL\n\xf0\x9f\x92\xb3 $V\n\xe2\x9c\x88\xef\xb8\x8f $BA\n\xf0\x9f\x9b\x92 $WMT $COST\n\xf0\x9f\x8e\xae $AMD $NVDA\n\xf0\x9f\x91\x9f $NKE\n\xf0\x9f\x92\xbc $CRM\n\xf0\x9f\x94\x8d $GOOGL\n\xf0\x9f\x9a\x91 $TDOC\n\xe2\x9c\x8f\xef\xb8\x8f $CHGG\n\xe2\x98\x95 $SBUX\n\xf0\x9f\x92\x8a $ABBV $BMY\n\xf0\x9f\x93\xa6 $UPS\n\xf0\x9f\x92\xbb $AMZN $SHOP\n\xf0\x9f\x97\xbc $AMT\n\xf0\x9f\x97\xa8\xef\xb8\x8f $FB $SNAP\n\xe2\x9a\xa1 $TSLA\n\xf0\x9f\x93\x88 Bitcoin ($GBTC)\n\xf0\x9f\x9b\x8d\xef\xb8\x8f $CPRI\n\xf0\x9f\x8e\xa2 $DIS\n\xf0\x9f\x94\x92 $CRWD\n\nJust a few! Trade on! \xe2\x9c\x85'
2021-01-08,"b'TUNE IN: #JPM21 is almost here! As always, @CNBCnow has a stellar, all-exclusive lineup. CEOs of $BNTX $GILD $ILMN $BMY $LLY $PFE $NVS $LH $MDT join @megtirrell and @jimcramer, starting Monday on @SquawkCNBC https://t.co/S4gBTd3bAQ'"
2021-01-08,"b'Today Top Flow in #healthcare sector, Buy Flow &amp; Sell Flow $PFE $MRK $ABBV $WAT $REGN $TMO $BAX $BMY $ISRG $BDX $ALXN $DGX $UNH $VAR $CAH $HUM $AMGN $CI $LLY $BSX #stock #stocks #StockMarket #Investment #investing #HealthTech https://t.co/5JE2nlrW3B https://t.co/xxjrtp6rQS'"
2021-01-08,b'$ONCS $ONCS $BMY - OncoSec announces first patient dosed in phase 2 trial of TAVO plus OPDIVO in skin cancer study https://t.co/u6eQhRZI7f'
2021-01-08,b'$BMY Financial metrics; presented on per share basis https://t.co/pgvmyJDCXR #PerShare #BMY https://t.co/kloEABYBy3'
2021-01-08,b'#UncleMyer clawing back to a bigger 63 level $BMY\n\nHolding a decent load of Mar 65s for a while.  Could be some good rotation here soon plus #Mavacamten data this Q\n\n$REGN also a big reversal. Thought lotto there yesterday too. No pull string \xf0\x9f\xa7\xa8\xf0\x9f\x99\x84'
2021-01-08,"b""RT @Biohazard3737: 7) Further, why was the area that caused the FDA's concerns not identified ahead of time during a 12 month long review?\xe2\x80\xa6"""
2021-01-08,"b'RT @Biohazard3737: 3) In addition to the reasons for the major amendment, the litigation will have to focus on the factors that caused this\xe2\x80\xa6'"
2021-01-08,"b'RT @Biohazard3737: Couple of final thoughts on $BMYRT:\n1) I believe, $BMY senior management expected a timely liso-cel approval after their\xe2\x80\xa6'"
2021-01-08,"b""7) Further, why was the area that caused the FDA's concerns not identified ahead of time during a 12 month long review? Did $BMY conduct mock inspections at Lonza?\n8) Was the 483 response sufficient or rushed? $BMYRT"""
2021-01-08,"b'3) In addition to the reasons for the major amendment, the litigation will have to focus on the factors that caused this.\n4) The key question is whether $BMY used diligent/best efforts to guarantee a successful outcome of the Lonza Inspection. $BMYRT'"
2021-01-08,"b'Couple of final thoughts on $BMYRT:\n1) I believe, $BMY senior management expected a timely liso-cel approval after their response on Dec 18th (based on mosaic theory/multiple sources)\n2) However, something else must have come up (additional information requests)'"
2021-01-08,b'It\xe2\x80\x99s all good tho $BMY is about to pull thru for me today'
2021-01-08,b'$BMY  A LITTLE MORE TACK ON BULL FLOW THIS MORNING'
2021-01-08,b'$Eliquis and $Xarelto are top dogs but heart failure and #strokedrugs may soon catchup. $Entresto is growing. @BrilintaUS is now approved for stroke. $SGLT2 inhibitors and a new #heartfailuredrug from $BMY will soon make inroads.\n\n#bigpharma #biotechnology #biotechnews https://t.co/IsKzADIO0e'
2021-01-08,b'$BMY entered a long here\n#swingtrade https://t.co/jQVKwDfVVg'
2021-01-08,"b'Large Print $BMY Size: 143277 Price: 62.19 Time: 930 Amount: $8,910,396.63'"
2021-01-08,"b'@Biotech2050 @bmsnews Forget CVRs. EVP and No 2 guy in the company leaving is material info for $BMY shareholders. The fact there is no PR yet but a part of investing community already know about this, is selective disbursement of news, and very very weird IF the rumor is true.'"
2021-01-08,b'Great news! Congrats! @bmsnews @EMA_News $BMY #gastric #cancer \nhttps://t.co/esFc6JHFs0 https://t.co/dCEXnbvsdb'
2021-01-08,"b'RT @DewDiligence: @bradloncar 1 $RVNC receives ~$5B buyout offer, which might not be accepted.\n2 $ENTA gets out of penalty box by making pr\xe2\x80\xa6'"
2021-01-08,b'OncoSec says first patient dosed in Phase 2 trial of TAVO plus OPDIVO \n$ONCS $BMY'
2021-01-08,b'RT @JediJazz22: 88% Buy rating on the $UMAX chart from https://t.co/B7r758QNzt today!\nhttps://t.co/w3YqZNYzLM $BAC $GE $WFC $MPW $AVP $F $N\xe2\x80\xa6'
2021-01-08,b'$ETH Market Cap is More than $SHOP $BMY $JD $WFC $C $UPS $AMGN https://t.co/WGBwO8GtHL'
2021-01-08,"b'Avidity Biosciences reports 2021 pipeline updates, research pact with MyoKardia \n$RNA $BMY'"
2021-01-08,"b'Strong Stocks  watch-list for trading on Jan 08, 2021 $QQQ $SPY $IWM #success #trading #options #stock #investing\n$COST $DG $MDLZ $SO $WMT $ACN $MDT $ADM $JNJ $BMY https://t.co/EsHZmSvMi2'"
2021-01-08,"b'""Aldoxorubicin appears to be the first anthracycline to cross the blood-brain barrier in GBM, potentially creating a new approach to attacking brain tumors,"" said Steven Kriegsman, Chairman, President &amp; CEO of CytRx Jan 06, 2015 $CYTR $IBRX $NK $CELG $BMY $JNJ $PFE @SquawkStreet'"
2021-01-08,b'RT @jq1234t: 1Q21 Catalysts:\n\n$AGIO Mitapivat Transfusion Dependent PKD ph3\n$BMRN Valrox Hemophilia A ph3\n$BMY Relatlimab(anti-LAG3) 1L Mel\xe2\x80\xa6'
2021-01-08,b'88% Buy rating on the $UMAX chart from https://t.co/B7r758QNzt today!\nhttps://t.co/w3YqZNYzLM $BAC $GE $WFC $MPW $AVP $F $NIO $APRN $SNAP $ECA $BABA $FCX $ABEV $TRNX $PTN $JNJ $AMRN $SLS $TEVA $CRMD $CYTX $SEEL $GERN $LIFE $CVM $AVEO $NVAX $NBIO $MRK $BMY $JNJ $MRK $GILD $REGN https://t.co/CWjkbgmnj6'
2021-01-08,b'88% Buy rating on the $UMAX chart from https://t.co/Fc6E1Gmc8u today!\nhttps://t.co/MUHkVyxHX7 $BAC $GE $WFC $MPW $AVP $F $NIO $APRN $SNAP $ECA $BABA $FCX $ABEV $TRNX $PTN $JNJ $AMRN $SLS $TEVA $CRMD $CYTX $SEEL $GERN $LIFE $CVM $AVEO $NVAX $NBIO $MRK $BMY $JNJ $MRK $GILD $REGN https://t.co/QOZam27jCZ'
2021-01-08,"b""BaML Next week's virtual conference (Jan 11-14) is first major Bio conference In terms of potential stock-moving updates, point to $REGN, $LLY, $RPRX, $PFE $VRTX $BMY"""
2021-01-08,"b""$BMY:\n\nNew Insider Filing on BRISTOL MYERS SQUIBB CO's\n\nDirector\n\nROBERT J BERTOLINI:\n\nhttps://t.co/NBySFEHR8S"""
2021-01-08,b'Asking for $BMYRT Holders @bmsnews @bmsnews \n\nIs the rumor that Nadim Ahmed left $BMY true?\n\nWhy would a high flier leave? \n\nWas he going to get the blame for the CVR fiasco so left before or is he going to \xe2\x80\x9cblow the whistle\xe2\x80\x9d loudly?'
2021-01-08,b'ArsenalBio Announces Multi-Program Discovery Collaboration with Bristol Myers Squibb to Advance Next-Generation T cell Ther.. $BMY https://t.co/c79ZpJjFsA'
2021-01-08,"b""$BMY's price moved above its 50-day Moving Average on December 30, 2020. View odds for this and other indicators: https://t.co/ctmATYPb41 #Bristol #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MbRg50WTgS"""
2021-01-08,b'#ArsenalBio Announces Multi-Program Discovery Collaboration with #BristolMyersSquibb to Advance Next-Generation #TCell Therapies for #SolidTumors $BMY https://t.co/V7nXY0hPHM'
2021-01-08,"b'Can anyone, for the love of god, tell me why $rdy dr reddys (a generic pharma company with no eps growth) trades at a 30x multiple, while $bmy (a company growing eps by double digit %) trades at a 9x multiple???!!!  @jimcramer #madtweets  bmy - worst acting stock of 2020 award'"
2021-01-08,b'01/07/2021 @SenatorCarper purchases $BMY #tradelikeasenator #congressionaltrades'
2021-01-08,b'@tejada444 @Biohazard3737 $27 treble punitive damages for deliberate delay $BMYRT $BMY #OneCanDream'
2021-01-08,"b'RT @Dividend_Dollar: Pharmaceuticals/Healthcare stocks are a great place to find growth, stability, and solid dividends\n\n$5K invested in EA\xe2\x80\xa6'"
2021-01-08,b'#JPM21 starts in 3 days which will be closely listened to by $BMYRT CVR holders @JohnCendpts @endpts. $BMY CEO right now if the embedded tweet is true: https://t.co/9uVNDtg7xA https://t.co/XG6ZetsciH'
2021-01-08,b'Hi @TGTherapeutics @SagarLonialMD \n\nIt seems that the top hematologist at $BMY (ex CELGENE) just resigned. Could be great to have him on the $TGTX team and then buyout or merge with @Karyopharm $KPTI \n\n@semodough https://t.co/9uVNDtg7xA'
2021-01-08,"b'RT @Biohazard3737: $BMYRT: Somebody just tweeted that $BMY head of hematology (ex CELG) resigned today (Nadim). Then locked the account, so\xe2\x80\xa6'"
2021-01-08,b'$BMY Check out this chart I made with @TrendSpider https://t.co/yq1YsKsU9D \n\nTrend break. Lets see if we can follow through.'
2021-01-08,b'ArsenalBio reaches next stage of maturity with BMS deal in which it will put its #SyntheticBiology toolkit to the test $BMY https://t.co/h4irFq53cm'
2021-01-08,"b'@Biohazard3737 It always been 0 or 9 for me. That\xe2\x80\x99s what i signed up for. If Bristol did something they shouldn\xe2\x80\x99t have, I\xe2\x80\x99m owed 9 -not 3, 4 or 5. If $bmy made diligent efforts navigating COVID, &amp; despite their efforts, it still wasn\xe2\x80\x99t approved - why should I get anything more than 0? $bmyrt'"
2021-01-08,"b'Strategic biotech investors Eli Lilly, Novo Ventures back Dutch early-stage investor BGV\xe2\x80\x99s largest-ever fund $LLY $BMY https://t.co/MJTkF4txHT'"
2021-01-08,"b'RT @Dividend_Dollar: Pharmaceuticals/Healthcare stocks are a great place to find growth, stability, and solid dividends\n\n$5K invested in EA\xe2\x80\xa6'"
2021-01-08,b'RT @jq1234t: 1Q21 Catalysts:\n\n$AGIO Mitapivat Transfusion Dependent PKD ph3\n$BMRN Valrox Hemophilia A ph3\n$BMY Relatlimab(anti-LAG3) 1L Mel\xe2\x80\xa6'
2021-01-08,"b'$BMY Broke trendline and avwap from recent high.  RSI back above 30sma and TTM in sqz.  On 12/31, there was $2.5mil in Feb $62.50s bought (still open) https://t.co/mQoJMhZW2h'"
2021-01-08,b'RT @jq1234t: 1Q21 Catalysts:\n\n$AGIO Mitapivat Transfusion Dependent PKD ph3\n$BMRN Valrox Hemophilia A ph3\n$BMY Relatlimab(anti-LAG3) 1L Mel\xe2\x80\xa6'
2021-01-08,b'They forgot the real puppeteers still here just been dealing w/ misfortunes shoutout $BMY though keeping my fam alive'
2021-01-08,b'RT @Biotech2050: #JPM21 #JPMorgan $BMY $TGTX $XLRN $KPTI $PGEN $ZIOP $ACAD $HALO $SGMO \n\nWhich other companies\xe2\x80\x99 presentations are you looki\xe2\x80\xa6'
2021-01-07,"b'If I may guess at a possible M&amp;A with $ONCO. $BMY focus is on Multiple Myeloma, Lymphoma and CLL, MDS, AML, MPNs.  https://t.co/RNoYSUuvOr $BMY ""long-term growth would be enabled largely by business Development."" M&amp;A pro with $200B https://t.co/I1vHejFD0h'"
2021-01-07,"b""$BMY:\n\nNew Insider Filing on BRISTOL MYERS SQUIBB CO's\n\nDirector\n\nDERICA W RICE:\n\nhttps://t.co/yfkVDFBW23"""
2021-01-07,"b'Tomorrow\xe2\x80\x99s #watchlist for #NYSE, #NASDAQ between $60 and $70: $ARCT $BMY $C $CNC $EWJ $GILD $IEMG $NEM $TJX $VXUS $XOP'"
2021-01-07,"b""What's Next $CERS $TEVA Also $BMY $NIO $NOK $RDY $SNY $TMO $VOD $ESALY $GELYF $NPSNY $RHHBY $MELI $PLUG $TSEM $CGEN $DIA $ZYME $TAK $TCOM https://t.co/GLTzSKUXqZ"""
2021-01-07,b'Short sale vol (not short interest) for $AZN on 2021-01-06 is 36%. https://t.co/hOqo099TrH $ABT 22% $BMY 22% $LLY 36% $JNJ 31%'
2021-01-07,"b'RT @Biohazard3737: $BMYRT: Somebody just tweeted that $BMY head of hematology (ex CELG) resigned today (Nadim). Then locked the account, so\xe2\x80\xa6'"
2021-01-07,"b""Thursday's Top Flow in #healthcare sector, Buy Flow &amp; Sell Flow $ALXN $HUM $GILD $MCD $BAX $WAT $SYK $LH $BSX $PKI $PFE $ZTS $BMY $UNH $CI $ABT $MDT $LLY $MRK $BIIB #stock #stocks #StockMarket #Investment #investing #HealthTech https://t.co/5JE2nlrW3B https://t.co/xhcqVn9TBN"""
2021-01-07,"b'RT @Biohazard3737: $BMYRT: Somebody just tweeted that $BMY head of hematology (ex CELG) resigned today (Nadim). Then locked the account, so\xe2\x80\xa6'"
2021-01-07,b'#EatonVance top sales in #Q32020 include  #Bristol-Myers Squibb Company $BMY . Read about the trade at https://t.co/4TV9OYgBGh'
2021-01-07,"b'$BMYRT: Somebody just tweeted that $BMY head of hematology (ex CELG) resigned today (Nadim). Then locked the account, so maybe it was internal communication?\n\nIn any case, the litigation here will be lit.'"
2021-01-07,b'BLOWOUT UP DAY!! $ARCT on fire. GREEN INK FLOOD!\n\nhttps://t.co/oqnENLGXM4\n\n$MRNA $NVAX $BNTX $CVAC $ADPT $ATRA $ALNY $EBS $INO $VXRT $VXRT $ONCS $SRNE $DVAX $ALT $IBIO $IMV $HTBX $TNXP $PDSB $NNVC $VBIV $GNBT $GOVX $VIR #JNJ #MRK #CovidVaccine #covid #PFE $GSK $BMY $ABT #pharma https://t.co/oIQtlVmBhX'
2021-01-07,"b""@Biohazard3737 @MartyBabitz @BiotechObserver If every buck per CVR costs $BMY $700 million, it's definitely in $BMY's interest to fight and plan to never pay anything except to lawyers."""
2021-01-07,b'Rolling along in my #tasty5kchallenge. Account closed at 7047 today thanks to good movements on $BMY $NIO and $CLVR.  Closed out $ROKU and $UNH positions for a nice gain. Next stop 8k! https://t.co/jpooVaTORb'
2021-01-07,b'$BMY 5 years of dividends...adds up! https://t.co/pgvmyJDCXR #Income #Dividend #AddsUp #BMY https://t.co/H8l5fT03Ij'
2021-01-07,b'$BMY Dividend stats https://t.co/pgvmyJDCXR #Income #Dividend #TheMoreYouKnow #BMY https://t.co/7Hx6GCEWTz'
2021-01-07,"b'Large Print $BMY Size: 668000 Price: 62.36 Time: 1602 Amount: $41,656,480.00'"
2021-01-07,"b'$IGPK Filings are hitting! Load the boat, shes about to go PINK CURRENT\n\nhttps://t.co/sDrhxiwI96\n\n$SNAP $ECA $BABA $FCX $ABEV $TRNX $PTN $JNJ $AMRN $SLS $TEVA $CRMD $CYTX $SEEL $GERN $LIFE $CVM $AVEO $NVAX $NBIO $MRK $BMY $JNJ $MRK $GILD $REGN $MRNA $PFE $ABT'"
2021-01-07,b'$HRAL ~ Blue Sky Breakout with Volume! +49% at .0149\nhttps://t.co/7EHbe4ne8P $BAC $GE $WFC $MPW $AVP $F $NIO $APRN $SNAP $ECA $BABA $FCX $ABEV $TRNX $PTN $JNJ $AMRN $SLS $TEVA $CRMD $CYTX $SEEL $GERN $LIFE $CVM $AVEO $NVAX $NBIO $MRK $BMY $JNJ $MRK $GILD $REGN $MRNA $PFE $ABT https://t.co/hmwshg4src'
2021-01-07,"b'RT @sharpie510: When the $nwbo adcom arrives, you can be assured there will be many influential #glioblastoma patient advocates like Dr. Mu\xe2\x80\xa6'"
2021-01-07,"b'$MRK breakout? piercing key overhead trendline(links Sept/Nov/Dec highs), MACD bull cross underneath, 50/200D scooping, long it, large, #merck Merck $PPH $pfe $abt $bmy $lly $spx https://t.co/TafEPeS7ee'"
2021-01-07,"b""$BMYRT Although based on past tweets, no one ever responds unless I ask them directly, I am interested in people's thoughts on why a further delay makes $BMY less liable instead of more, as it would imply that there were more problems with their Lonza inspection/response"""
2021-01-07,"b'RT @Dividend_Dollar: Pharmaceuticals/Healthcare stocks are a great place to find growth, stability, and solid dividends\n\n$5K invested in EA\xe2\x80\xa6'"
2021-01-07,b'RT @Biotech2050: #JPM21 #JPMorgan $BMY $TGTX $XLRN $KPTI $PGEN $ZIOP $ACAD $HALO $SGMO \n\nWhich other companies\xe2\x80\x99 presentations are you looki\xe2\x80\xa6'
2021-01-07,b'RT @RapidTrading: Unbelievable morning $DDD 1000% and  780% $TSLA 250% $MARA 100% $TRIP 80% $SPY 50% $ROKU 400% $SNOW 100% and 80% puts $BM\xe2\x80\xa6'
2021-01-07,"b""RT @SPGMIHealthcare: EXCLUSIVE: Bristol Myers M&amp;A strategy leader enters 2021 with 'stronger sense of urgency', @MichaelHGibney reports\nhtt\xe2\x80\xa6"""
2021-01-07,"b'RT @sharpie510: When the $nwbo adcom arrives, you can be assured there will be many influential #glioblastoma patient advocates like Dr. Mu\xe2\x80\xa6'"
